These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 31076698)

  • 41. Effect of Preoperative Intramuscular Injection of Botulinum Toxin A on Pain and Mouth Opening After Surgical Intervention in Temporomandibular Joint Ankylosis Cases: A Controlled Clinical Trial.
    Shandilya S; Mohanty S; Sharma P; Chaudhary Z; Kohli S; Kumar RD
    J Oral Maxillofac Surg; 2020 Jun; 78(6):916-926. PubMed ID: 32171600
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Botulinum toxin for myofascial pain syndromes in adults.
    Soares A; Andriolo RB; Atallah AN; da Silva EM
    Cochrane Database Syst Rev; 2012 Apr; (4):CD007533. PubMed ID: 22513950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The use of botulinum toxin for the treatment of temporomandibular disorders: preliminary findings.
    Freund B; Schwartz M; Symington JM
    J Oral Maxillofac Surg; 1999 Aug; 57(8):916-20; discussion 920-1. PubMed ID: 10437718
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A clinical evaluation of botulinum toxin-A injections in the temporomandibular disorder treatment.
    Kim HS; Yun PY; Kim YK
    Maxillofac Plast Reconstr Surg; 2016 Dec; 38(1):5. PubMed ID: 26855937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Botulinum toxin in the management of myalgia in temporomandibular disorders: are all injections equal?
    Anwar H; Attard A; Green J; Elledge ROC
    Br J Oral Maxillofac Surg; 2023 Jan; 61(1):89-93. PubMed ID: 36522255
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of clinical marking and ultrasound-guided injection of Botulinum type A toxin into the masseter muscles for treating bruxism and its cosmetic effects.
    Quezada-Gaon N; Wortsman X; Peñaloza O; Carrasco JE
    J Cosmet Dermatol; 2016 Sep; 15(3):238-44. PubMed ID: 26799545
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biofeedback for treatment of chronic idiopathic constipation in adults.
    Woodward S; Norton C; Chiarelli P
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD008486. PubMed ID: 24668156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Temporomandibular disorders in 19-year-old Korean men.
    Choi YS; Choung PH; Moon HS; Kim SG
    J Oral Maxillofac Surg; 2002 Jul; 60(7):797-803. PubMed ID: 12089696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship between bruxism and temporomandibular disorders: a systematic review of literature from 1998 to 2008.
    Manfredini D; Lobbezoo F
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jun; 109(6):e26-50. PubMed ID: 20451831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of botulinum toxin in the management of temporomandibular myofascial pain and sleep bruxism.
    Hosgor H; Altindis S
    J Korean Assoc Oral Maxillofac Surg; 2020 Oct; 46(5):335-340. PubMed ID: 33122458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is myasthenia gravis a contraindication for botulinum toxin?
    Ma Q; Ran H; Ou C; Liu X; Lu Y; Huang H; Yang W; Yu L; Chen P; Huang X; Qiu L; Lin Z; Huang Z; Liu W
    J Clin Neurosci; 2022 Jan; 95():44-47. PubMed ID: 34929650
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sleep and awake bruxism in adults and its relationship with temporomandibular disorders: A systematic review from 2003 to 2014.
    Jiménez-Silva A; Peña-Durán C; Tobar-Reyes J; Frugone-Zambra R
    Acta Odontol Scand; 2017 Jan; 75(1):36-58. PubMed ID: 27796166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An evidence-based assessment of occlusal adjustment as a treatment for temporomandibular disorders.
    Tsukiyama Y; Baba K; Clark GT
    J Prosthet Dent; 2001 Jul; 86(1):57-66. PubMed ID: 11458263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Managements of sleep bruxism in adult: A systematic review.
    Minakuchi H; Fujisawa M; Abe Y; Iida T; Oki K; Okura K; Tanabe N; Nishiyama A
    Jpn Dent Sci Rev; 2022 Nov; 58():124-136. PubMed ID: 35356038
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bruxism secondary to brain injury treated with botulinum toxin-A: a case report.
    El Maaytah M; Jerjes W; Upile T; Swinson B; Hopper C; Ayliffe P
    Head Face Med; 2006 Nov; 2():41. PubMed ID: 17123443
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment of severe bruxism with botulinum toxin type A].
    Alonso-Navarro H; Jiménez-Jiménez FJ; Plaza-Nieto JF; Pilo-De la Fuente B; Navacerrada F; Arroyo-Solera M; Calleja M
    Rev Neurol; 2011 Jul; 53(2):73-6. PubMed ID: 21720976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sleep bruxism and temporomandibular disorders: A scoping review of the literature.
    Manfredini D; Lobbezoo F
    J Dent; 2021 Aug; 111():103711. PubMed ID: 34090993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Occlusal adjustment for treating and preventing temporomandibular joint disorders.
    Koh H; Robinson PG
    Cochrane Database Syst Rev; 2003; (1):CD003812. PubMed ID: 12535488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Profile of TMD and Bruxer compared to TMD and nonbruxer patients regarding chief complaint, previous consultations, modes of therapy, and chronicity.
    Molina OF; dos Santos Júnior J; Nelson SJ; Nowlin T
    Cranio; 2000 Jul; 18(3):205-19. PubMed ID: 11202839
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Botulinum toxin and occlusal splints for the management of sleep bruxism in individuals with implant overdentures: A randomized controlled trial.
    Ali SM; Alqutaibi AY; Aboalrejal A; Elawady DM
    Saudi Dent J; 2021 Dec; 33(8):1004-1011. PubMed ID: 34938043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.